✦ LIBER ✦

The use of intermediate dose cytosine arabinoside (ID Ara-C) in the treatment of acute non-lymphocytic leukaemia in relapse

✍ Scribed by H. C. van Prooijen; A. W. Dekker; K. Punt

Book ID: 114710195
Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 509 KB
Volume: 57
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1984.tb02898.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low dose cytosine arabinoside in the tre

Low dose cytosine arabinoside in the treatment of acute non-lymphocytic leukaemia

✍ Jensen, Mogens Krogh ;Ahlbom, Göran 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 209 KB

Clofarabine and high-dose cytosine arabi

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia

✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 98 KB

Clofarabine (40 mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel

Treatment of minimal residual disease in

Treatment of minimal residual disease in poor risk acute lymphoblastic leukaemia with high-dose cytosine arabinoside (ARA-C)

✍ M.J. Barnett; J.E. Kingston; A. Miller; L.K. Goff; T.S. Ganesan; R. Biruls; A.Z. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 93 KB

High-dose VP-16 with intermediate-dose c

High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia

✍ Hon Y. Chan; Frederick J. Meyers; Jerry P. Lewis 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 147 KB

Fludarabine and cytosine arabinoside in

Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia

✍ Samer Suki; Hagop Kantarjian; Varsha Gandhi; Elihu Estey; Susan O'Brien; Milosla 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Background: The objectives of the study were to evaluate the antileukemic efficacy and toxicity profiles of the combination of fludarabine and intermediate-dose cytosine arabinoside (ara-c) in refractory or relapsed adult acute lymphocytic leukemia (all). patients and methods. thirty adults with

Treatment of acute nonlymphocytic leukem

Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside

✍ Letendre, Louis ;Niedringhaus, Robert D. ;Therneau, Terry M. ;Gastineau, Dennis 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 1 views

Effective treatment of the elderly patients (265 years) with acute nonlymphocytic leukemia (ANLL) remains elusive and controversial. In the present study, single-agent Cytosine Arabinoside (AM-C) was administered at an intermediate dose level (500 mg/m2 intravenously [I.V.] I-hour infusion q12 hours